dddmag.com
Drug Discovery & Development  
  NEWSLETTERS      |      WHITE PAPERS      |      SUBSCRIBE      |      ADVERTISE      |      CONTACT US      |      ABOUT US    

  Today is: 

News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News






SITE SPONSORS 
Advertise with Us
 

Browse Pharma/Biotech News:


J&J Donating $200M to UN Program
Health giant Johnson & Johnson is donating about $200 million in cash and medicine to a sweeping United Nations program created to improve the health and lives of people in poor countries.  continue
Linda A. Johnson


Emergent's Trubion Buyout Given All-Clear
The planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle, bringing the deal, potentially worth $135.5 million, closer to closing.  continue



 Woman Receives $21M In Side Effect Suit
A federal jury in New Hampshire has awarded $21 million to a woman blinded and scarred by a prescription drug she took for shoulder pain.  continue
Lynne Tuohy


Telaprevir Achieves 65% SVR in REALIZE Study
Vertex Pharmaceuticals Incorporated announced that 65% of people overall achieved a sustained viral response (viral cure) with a telaprevir-based regimen in the Phase 3 REALIZE study, compared to 17% of people who received pegylated-interferon and ribavirin alone.  continue



 IMP321 Achieves Benefit in MBC Patients
Immutep S.A. announced the publication of a clinical research paper showing that its lead product, IMP321, given with first-line paclitaxel achieved clinical benefit in 90% of metastatic breast carcinoma patients.  continue



 Seaside Study Shows Improvement in Irritability in ASD
Seaside Therapeutics, Inc. announced positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD).  continue



 PolyTherics And DSM In Manufacture Agreement
DSM BioSolutions and PolyTherics Limited, an innovator in precision engineering of proteins, announced that they have entered into an agreement for the process development and manufacture of PolyTherics’ lead biobetter product, HiPEG IFN α-2a.  continue



 Abbott Acquires Second-Largest Pharma in India
Abbott has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets.  continue



 BMS Set to Buy ZymoGenetics for $885M
Bristol-Myers Squibb Co. said it will acquire biotechnology partner ZymoGenetics Inc. for $885 million in another move by a major drugmaker to boost its pipeline by snapping up a smaller developer.  continue
Marley Seaman


Merck to Begin Arbitration With J&J
Drugmaker Merck & Co. said that arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis and other immune disorders.  continue
Linda A. Johnson




Most Popular


  1. Study Demonstrates Benefits of Cannabis for Pain

  2. Botox Case Settled for $600M

  3. Berries Activate Brain's Housekeeping Mechanism

  4. Obama Stem Cell Regulations Temporarily Blocked

  5. More Problems At J&J Subsidiary

  6. Abnormal Weight A Colon Cancer Risk Factor

  7. A Novel Approach to Treating Peripheral Arterial Disease

  8. Japan Confirms Presence of Superbug Gene

  9. NIH Finds Promising Staph Treatment

  10. FDA Approves Tekamlo